6C46.21

ICD-11 MMS 2026-01

Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission

Description

After a diagnosis of Stimulant dependence including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from stimulants during a period lasting between 1 and 12 months.

Index terms

  • Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission

Excludes

  • 6C46.0 – Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
  • 6C46.1 – Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone

Exclusions from above levels

  • 6C45.2 – Cocaine dependence
  • 6C47.2 – Synthetic cathinone dependence
  • 6C45 – Disorders due to use of cocaine
Show allHide
  • 6C47 – Disorders due to use of synthetic cathinones
  • 6C48 – Disorders due to use of caffeine
  • QE11.4 – Hazardous use of stimulants including amphetamines or methamphetamine
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C46.20 – Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use
  • 6C46.22 – Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
  • 6C46.23 – Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission
  • 6C46.2Z – Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified

Foundation entity

Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission – http://id.who.int/icd/entity/113814852

Allowed postcoordination axes

Part of: 6C46.2: Stimulant dependence including amphetamines, methamphetamine or methcathinone › 6C46: Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone › 06: Mental, behavioural or neurodevelopmental disorders